Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions his Department has had with NICE on the availability of Dinutuximab Beta on the NHS.
Departmental officials regularly discuss a range of issues with colleagues in the National Institute for Health and Care Excellence, and have had a number of discussions about the ongoing technology appraisal of dinutuximab beta for the treatment of high-risk neuroblastoma.